It’s Nurse Practitioners Week, and today, we have a special episode to highlight a historic moment in time.
On November 11, the FDA changed the labeling on hormone replacement therapy.
Join me for a short, focused episode where I read a recently published JAMA article detailing those changes, to keep you up to date on this significant development.
IN THIS EPISODE, YOU WILL LEARN:
-
How recent FDA updates are changing menopausal hormone therapy
-
The history of estrogen’s role in heart and bone health
-
How past research sparked fear around hormone therapy
-
What the new labeling means for patients and prescribers
-
How individualized treatment is reshaping dosage and timing decisions.
-
Updated FDA labeling now distinguishes between systemic and topical therapies
-
Key considerations for menopause-related urinary and genital health
-
How these updates will potentially impact women’s long-term health
Connect with Cynthia Thurlow
